Protalix BioTherapeutics
(NYSEMKT) PLX
Protalix BioTherapeutics Financials at a Glance
Market Cap
$174.84M
Revenue (TTM)
$76.38M
Net Income (TTM)
$15.33M
EPS (TTM)
$0.18
P/E Ratio
11.84
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$2.20
Volume
347,441.343
Open
$2.15
Price
$2.20
Volume
347,441.343
Open
$2.15
Previous Close
$2.17
Daily Range
$2.13 - $2.23
52-Week Range
$1.36 - $3.19
Estimated Earnings Date
May 8, 2026
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$2.20
Volume
347,441.343
Open
$2.15
Previous Close
$2.17
Daily Range
$2.13 - $2.23
52-Week Range
$1.36 - $3.19
Estimated Earnings Date
May 8, 2026
PLX News
Is This Orphan Drugmaker in Trouble?
5 of Last Week's Biggest Losers
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Protalix BioTherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
226
CEO
Dror Bashan, MBA
Website
www.protalix.comHeadquarters
Hackensack, NJ 07601, US
PLX Financials
Key Financial Metrics (TTM)
Gross Margin
69.97%
Operating Margin
25.91%
Net Income Margin
20.07%
Return on Equity
28.10%
Return on Capital
-9.73%
Return on Assets
14.98%
Earnings Yield
8.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$174.84M
Shares Outstanding
80.57M
Volume
347.44K
Avg. Volume
749.38K
Financials (TTM)
Gross Profit
$53.44M
Operating Income
$19.79M
EBITDA
$22.33M
Operating Cash Flow
$15.09M
Capital Expenditure
-$455.00K
Free Cash Flow
$14.64M
Cash & ST Invst.
$51.79M
Total Debt
$8.48M
Protalix BioTherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$33.75M
+233.7%
Gross Profit
$29.62M
+1432.5%
Gross Margin
87.77%
N/A
Market Cap
$174.84M
N/A
Market Cap/Employee
$755.81K
N/A
Employees
231.33
N/A
Net Income
$18.32M
+606.1%
EBITDA
$21.74M
+743.1%
Quarterly Fundamentals
Total Cash
$51.79M
+49.1%
Total Debt
$8.48M
+62.0%
Accounts Receivable
$2.94M
-37.1%
Inventory
$30.47M
+56.2%
Long Term Debt
$7.05M
+84.9%
Short Term Debt
$1.43M
+0.6%
Return on Assets
14.98%
N/A
Return on Invested Capital
26.41%
N/A
Free Cash Flow
$21.26M
+496.4%
Operating Cash Flow
$22.03M
+535.4%